Brooke E. Sylvester, Ph.D.
Affiliations: | 2011 | Cancer Biology | University of Chicago, Chicago, IL |
Area:
Genetics, Molecular Biology, OncologyGoogle:
"Brooke Sylvester"Parents
Sign in to add mentor| Olufunmilayo I. Olopade | grad student | 2011 | Chicago | |
| (Molecular genetics of colorectal cancer progression in a diverse hospital-based study.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhang Y, Doran C, Le TK, et al. (2023) Adverse events and clinical outcomes in patients treated with PD-(L)1 blockade for advanced non-small-cell lung cancer. Future Oncology (London, England) |
| Alatise OI, Knapp GC, Sharma A, et al. (2021) Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insights. Nature Communications. 12: 6821 |
| Hanrahan AJ, Sylvester BE, Chang MT, et al. (2020) Leveraging systematic functional analysis to benchmark an in silico framework distinguishes driver from passenger MEK mutants in cancer. Cancer Research |
| Gao J, Chang MT, Johnsen HC, et al. (2017) 3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targets. Genome Medicine. 9: 4 |
| Gao J, Chang MT, Sylvester BE, et al. (2016) Abstract 3606: Identification of oncogenic mutation hotspots via three-dimensional proximity Cancer Research. 76: 3606-3606 |
| Sylvester BE, Vakiani E. (2015) Tumor evolution and intratumor heterogeneity in colorectal carcinoma: insights from comparative genomic profiling of primary tumors and matched metastases. Journal of Gastrointestinal Oncology. 6: 668-75 |
| Diamond EL, Durham BH, Haroche J, et al. (2015) Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms. Cancer Discovery |
| Grisham RN, Sylvester BE, Won H, et al. (2015) Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology |
| Grimm WA, Messer JS, Murphy SF, et al. (2015) The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon. Gut |
| Arcila ME, Drilon A, Sylvester BE, et al. (2015) MAP2K1 (MEK1) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1935-43 |